Literature DB >> 8794357

The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels.

G D Ewart1, T Sutherland, P W Gage, G B Cox.   

Abstract

Vpu is a small phosphorylated integral membrane protein encoded by the human immunodeficiency virus type 1 genome and found in the endoplasmic reticulum and Golgi membranes of infected cells. It has been linked to roles in virus particle budding and degradation of CD4 in the endoplasmic reticulum. However, the molecular mechanisms employed by Vpu in performance of these functions are unknown. Structural similarities between Vpu and the M2 protein of influenza A virus have raised the question of whether the two proteins are functionally analogous: M2 has been demonstrated to form cation-selective ion channels in phospholipid membranes. In this paper we provide evidence that Vpu, purified after expression in Escherichia coli, also forms ion channels in planar lipid bilayers. The channels are approximately five- to sixfold more permeable to sodium and potassium cations than to chloride or phosphate anions. A bacterial cross-feeding assay was used to demonstrate that Vpu can also form sodium-permeable channels in vivo in the E. coli plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794357      PMCID: PMC190763     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system.

Authors:  Y A Lu; P Clavijo; M Galantino; Z Y Shen; W Liu; J P Tam
Journal:  Mol Immunol       Date:  1991-06       Impact factor: 4.407

2.  The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release.

Authors:  T Klimkait; K Strebel; M D Hoggan; M A Martin; J M Orenstein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

3.  Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein.

Authors:  K Strebel; T Klimkait; F Maldarelli; M A Martin
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  A novel gene of HIV-1, vpu, and its 16-kilodalton product.

Authors:  K Strebel; T Klimkait; M A Martin
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

5.  The reconstitution of functional respiratory chains in membranes from electron-transport-deficient mutants of Escherichia coli as demonstrated by quenching of atebrin fluorescence.

Authors:  B A Haddock; J A Downie
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

6.  The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation.

Authors:  S Bour; U Schubert; K Strebel
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Functional role of human immunodeficiency virus type 1 vpu.

Authors:  E F Terwilliger; E A Cohen; Y C Lu; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

8.  A rapid method for reconstitution of bacterial membrane proteins.

Authors:  A Varadhachary; P C Maloney
Journal:  Mol Microbiol       Date:  1990-08       Impact factor: 3.501

9.  Specific structural alteration of the influenza haemagglutinin by amantadine.

Authors:  R J Sugrue; G Bahadur; M C Zambon; M Hall-Smith; A R Douglas; A J Hay
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

10.  Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel.

Authors:  R J Sugrue; A J Hay
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  105 in total

1.  Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1.

Authors:  F M Marassi; C Ma; H Gratkowski; S K Straus; K Strebel; M Oblatt-Montal; M Montal; S J Opella
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  vpu transmembrane peptide structure obtained by site-specific fourier transform infrared dichroism and global molecular dynamics searching.

Authors:  A Kukol; I T Arkin
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

3.  The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons.

Authors:  S C Piller; G D Ewart; D A Jans; P W Gage; G B Cox
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation.

Authors:  A Deora; L Ratner
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Comparative structural studies of Vpu peptides in phospholipid monolayers by x-ray scattering.

Authors:  Songyan Zheng; Joseph Strzalka; David H Jones; Stanley J Opella; J Kent Blasie
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

6.  Molecular dynamics simulations on the first two helices of Vpu from HIV-1.

Authors:  I Sramala; V Lemaitre; J D Faraldo-Gómez; S Vincent; A Watts; W B Fischer
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

7.  The NB protein of influenza B virus is not necessary for virus replication in vitro.

Authors:  Masato Hatta; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity.

Authors:  T Watanabe; S Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

9.  Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Authors:  Raphaël Vigan; Stuart J D Neil
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

10.  Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs.

Authors:  Sang Ho Park; Stanley J Opella
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.